AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) held a meeting to discuss its FY2020 plans among Alliance members.

AMR Alliance Japan, as an independent platform for multisector discussion with the mission of contributing to the improvement of public health by promoting measures on AMR, will continue to work with Alliance members and partner organizations to deepen policy debate around AMR.

In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.

■Overview
Date and time: Monday, March 23, 2020
Organizer: AMR Alliance Japan (Secretariat: HGPI)

■Discussion
Participants (alphabetical order by last name):
Kyoko Ama (Representative, Ippan Shadan Hojin Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai)
Midori Hirai (Chair, Pharmaceutical Education Committee, The Pharmaceutical Society of Japan / Director, Japanese Red Cross Hyogo Blood Center)
Masashi Kawata (Senior Manager, Public Affairs & Policy, Corporate Affairs, Health & Value, Pfizer Japan Inc.)
Hiroshi Kiyota (President, Japanese Society of Chemotherapy / Professor, Department of Urology, The Jikei University Katsushika Medical Center)
Matt McEnany (Manager, HGPI)
Yuri Miura (Senior Industry Policy Specialist, Public and Industrial Policy, Health Policy, MSD K.K.)
Yuichi Muraki (Representative, Japanese Society of Pharmaceutical Health Care and Sciences / Professor, Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University)
Toshiyuki Sakaeda (President, The Japanese Society of Therapeutic Drug Monitoring / Professor, Department of Pharmacokinetics, Kyoto Pharmaceutical University)
Takuko Sawada (Director of the Board, Executive Vice President, Shionogi & Co., Ltd.)
Kazutoshi Shibuya (President, The Japanese Society for Medical Mycology / Professor, Department of Surgical Pathology, Toho University)
Satoshi Takagi (Business Director, Integrated Diagnostic Solutions, Medication Management Solutions, Nippon Becton Dickinson Company, Ltd.)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)

Moderator:
Tomohito Shibata (Senior Associate, HGPI)